Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Elastomeric Infusion Pumps Market – Insights

Elastomeric infusion pumps, also known as disposable balloon pumps, are used to administer IV drugs such as local anesthetics, antibiotics, and anti-neoplastics. These non-electronic, non-gravity driven devices are used in single infusions. Elastomeric infusion pumps contain a stretchable balloon reservoir that is filled with a drug and pressure from the elastic walls drives fluid delivery with relatively consistent pressure until it reaches near the end of the infusion.

The global elastomeric infusion pumps market is estimated to account for US$ 1,595.0 Mn in terms of value by the end of 2027

Global Elastomeric Infusion Pumps Market: Drivers

Post-operative pain in surgeries such as total knee replacement and total hip replacement is usually treated by infusion of analgesics through disposable infusion pumps. Therefore, increasing number of orthopedic procedures and surgeries is expected to boost growth of the global elastomeric infusion pumps market over the forecast period. For instance, The 2018 Annual Report of American Academy of Orthopedic Surgeons, over 1 million patients and over 1.4 million hip and knee arthroplasty procedures were entered into the American Joint Replacement Registry.

Moreover, elastomeric infusion pumps are cheaper and have fewer adverse effects compared to electronic pumps, which increases their adoption in ambulatory chemotherapy infusion centers. Moreover, as elastomeric infusion pumps do not require electricity to operate, the risk for free flow of medication to patients is eliminated. Such advantages of elastomeric infusion pumps over their electric counterparts is also expected to boost growth of the market.  

North America region held dominant position in the global elastomeric infusion pumps market in 2018, accounting for 33.0% share in terms of value, followed by Asia Pacific.

Elastomeric Infusion Pumps  | Coherent Market Insights

Global Elastomeric Infusion Pumps Market: Restraints

The costs of elastomeric infusion pumps keeps fluctuating depending on the type of the pumps. For instance, the cost of pumps administering antibiotics is significantly low, whereas the cost of pumps administering pain management drugs is relatively high and ranges between US$ 160 and US$ 450. Such scenario is expected to hinder growth of the global elastomeric infusion pumps market over the forecast period.

Moreover, stringent regulations regarding the use of plastics in elastomeric infusion pumps is also expected to hamper the market growth. For instance, the European Commission and the U.S. FDA published a safety assessments of medical devices containing Di (2-ethylhexyl) phthalate (DEHP) and plasticized polyvinylchloride (PVC) in parts of elastomeric infusion pumps. Therefore, manufacturers need to focus on for proper safety labeling of products to avoid severe side effects, especially in neonatal patient population.

Global Elastomeric Infusion Pumps Market: Opportunities 

Elastomeric infusion pumps can be used in portable regional anesthesia. Several studies have also demonstrated that the use of elastomeric infusion device following shoulder surgery allows safe and early discharge of patients with decreased need for parenteral opiate analgesia. Moreover, use of elastomeric infusion pumps in portable regional anesthesia is increasing in ambulatory care centers, dental care units, and cancer care centers the U.S., which is expected to offer lucrative growth opportunities for market players.

Moreover, increasing adoption of elastomeric infusion pumps in administration of chemotherapy drugs at ambulatory care centers and home care setting is also expected to offer significant growth opportunities for market players. Use of elastomeric infusion pumps aid in reducing wastage of chemotherapy drugs, which further helps in reducing cost of the treatment.

Global Continuous Rate Elastomeric Pumps elastomeric infusion pumps segment was valued at US$ 515.1 Mn market in 2018 and is forecast to reach a value of US$ 1,095.1 Mn by 2027 at a CAGR of 8.8% between 2019 and 2027

Elastomeric Infusion Pumps  | Coherent Market Insights

Global Elastomeric Infusion Pumps Market: Market Trends

Increasing R&D for novel applications of elastomeric infusion pumps is a recent trend in the market. For instance, in September 2018, researchers from University Hospital of Lausanne, Switzerland, assessed the use of two submuscular catheters connected to two elastomeric pumps in postoperative continuous wound infiltration of levobupivacaine. 

Moreover, increasing use of elastomeric infusion pumps outpatient parenteral antimicrobial therapy is also expected to boost growth of the market. For instance, in 2018, a study in Journal of Antimicrobial Chemotherapy concluded that continuous infusions of flucloxacillin, cefepime, vancomycin and piperacillin/tazobactam using elastomeric infusion pumps is effective in outpatient parenteral antimicrobial therapy.

Global Elastomeric Infusion Pumps Market: Regulations

Key players in the market need to focus on effects of temperature, fill volume, and diluent on flow rates in elastomeric infusion pumps. Proper labelling of flow rates and monitoring of models as per desired infusion time is also important while production of the infusion pumps.

Global Elastomeric Infusion Pumps Market: Competitive Landscape

Key players in the market are focused on integrating elastomeric infusion pumps with other digital technologies. For instance, in April 2017, B. Braun Medical Inc. integrated its Easypump ST/LT Elastomeric Infusion Pump System with an innovative app that offers educational content to clinicians and patients on the safe use and features of the Easypump for short- and long-term home infusion therapy.

Major players operating in the global elastomeric infusion pumps market include, B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation.

Elastomeric infusion pumps are non-electronic medication pumps also called as balloon pumps which are used for infusion of analgesics, chemotherapy drugs, local anesthetics, antibiotics and other type of medication. Elastomeric infusion pumps are single use medical devices used for drug infusion. The process of infusion is carried out with the help of consistent pressure created in the elastomeric layer present in the pump which is controlled with the help of flow restrictors located in the elastomeric reservoir.

Key features of the study:

  • This report provides in-depth analysis of the Elastomeric Infusion Pumps market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Elastomeric Infusion Pumps market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Elastomeric Infusion Pumps market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Elastomeric Infusion Pumps market

Detailed Segmentation:

Segmentation

Scope of the report

  • Elastomeric infusion pumps Market, By Product Type:
    • Variable Rate Elastomeric Pumps
    • Continuous Rate Elastomeric Pumps
  • Elastomeric infusion pumps Market, By Treatment:
    • Pain Management
    • Antibiotic/Antiviral
    • Chemotherapy
    • Others
  • Elastomeric infusion pumps Market, By End User:
    • Ambulatory Surgical Centers
    • Clinics
    • Home Care Settings
    • Hospitals
    • Others
  • Elastomeric infusion pumps Market, By Region:
    • North America
      • By Device Type:
        • Variable Rate Elastomeric Pumps
        • Continuous Rate Elastomeric Pumps
      • By Treatment
        • Pain Management
        • Antibiotic/Antiviral
        • Chemotherapy
        • Others
      • By End User:
        • Ambulatory Surgical Centers
        • Clinics
        • Home Care Settings
        • Hospitals
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Device Type:
        • Variable Rate Elastomeric Pumps
        • Continuous Rate Elastomeric Pumps
      • By Treatment
        • Pain Management
        • Antibiotic/Antiviral
        • Chemotherapy
        • Others
      • By End User:
        • Ambulatory Surgical Centers
        • Clinics
        • Home Care Settings
        • Hospitals
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Device Type:
        • Variable Rate Elastomeric Pumps
        • Continuous Rate Elastomeric Pumps
      • By Treatment
        • Pain Management
        • Antibiotic/Antiviral
        • Chemotherapy
        • Others
      • By End User:
        • Ambulatory Surgical Centers
        • Clinics
        • Home Care Settings
        • Hospitals
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Device Type:
        • Variable Rate Elastomeric Pumps
        • Continuous Rate Elastomeric Pumps
      • By Treatment
        • Pain Management
        • Antibiotic/Antiviral
        • Chemotherapy
        • Others
      • By End User:
        • Ambulatory Surgical Centers
        • Clinics
        • Home Care Settings
        • Hospitals
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Device Type:
        • Variable Rate Elastomeric Pumps
        • Continuous Rate Elastomeric Pumps
      • By Treatment
        • Pain Management
        • Antibiotic/Antiviral
        • Chemotherapy
        • Others
      • By End User:
        • Ambulatory Surgical Centers
        • Clinics
        • Home Care Settings
        • Hospitals
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Device Type:
        • Variable Rate Elastomeric Pumps
        • Continuous Rate Elastomeric Pumps
      • By Treatment
        • Pain Management
        • Antibiotic/Antiviral
        • Chemotherapy
        • Others
      • By End User:
        • Ambulatory Surgical Centers
        • Clinics
        • Home Care Settings
        • Hospitals
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • B. Braun Melsungen AG *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Fresenius Kabi
    • Leventon, S.A.U
    • Ambu A/S
    • Baxter International Inc.
    • Halyard Health
    • Nipro Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Treatment
      • Market Snippet, By End User
      • Market Snippet, By Region Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Awareness Initiatives
    • PEST Analysis
    • Epidemiology
  4. Global Elastomeric Infusion Pumps Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Variable Rate Elastomeric Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Continuous Rate Elastomeric Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Elastomeric Infusion Pumps Market, By Treatment, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Pain management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Antibiotic/Antiviral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Chemotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Elastomeric Infusion Pumps Market, By End User, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Home Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Elastomeric Infusion Pumps Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Company Profiles
      • B. Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fresenius Kabi
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Leventon, S.A.U
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Ambu A/S
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Halyard Health
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nipro Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 38 market data tables and 40 figures on “Elastomeric Infusion Pumps Market - Global forecast to 2027”.

Frequently Asked Questions

The global elastomeric infusion pumps market estimated to account for US$ 1,595.0 Mn, in terms of value by the end of 2027.
Major players operating in the elastomeric infusion pumps market include B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation.
Fluctuating costs of elastomeric infusion pumps and stringent regulations about the usage of plastics in elastomeric infusion pumps are the factors that are expected to hamper growth of the market over the forecast period.
The increasing adoption of elastomeric infusion pumps in administration of chemotherapy drugs at ambulatory care centers and home care setting, coupled with higher efficiency over electronic pumps are the factors that are expected to drive growth of the market.
Among product type, continuous rate elastomeric pumps segment accounted for a major market share of US$ 515.1 Mn in 2018, and is expected to reach US$ 1,095.1 Mn by 2027, exhibiting a CAGR of 8.8% over the forecast period (2019-2027). This is attributed to the ability of continuous flow pumps to offer less errors due to recurrent infusion.
Among regions, North America held a dominant position in the global elastomeric infusion pumps market in 2018, accounting for 33.0% market share, in terms of value, followed by Asia Pacific.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner